HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1.

Abstract
Structural optimization of recently discovered new chemical entity, 2,8-dicyclopentyl-4-methylquinoline (DCMQ; MIC= 6.25 microg/mL, M. tuberculosis H37Rv) resulted in the synthesis of four new series of ring-substituted quinolinecarboxylic acids/esters constituting 45 analogues. All new derivatives were evaluated for in vitro antimycobacterial activities against M. tuberculosis H37Rv. Certain ring-substituted-2-quinolinecarboxylic acid ester and ring-substituted-2-quinoline acetic acid ester analogues described herein showed moderate to good inhibitory activity. In particular, three analogues methyl 4,5-dicyclopentyl-2-quinolinecarboxylate (3b), methyl 4,8-dicyclopentyl-2-quinolinecarboxylate (3c) and ethyl 2-(2,8-dicyclopentyl-4-quinolyl)acetate (14g) exhibited excellent MIC values of 1.00, 2.00 and 4.00microg/mL, respectively. Results obtained indicate that substitution of the quinoline ring with dicyclopentyl substituent presumably enhances the antimycobacterial activities in the quinoline analogues described herein.
AuthorsBalasubramanian Vaitilingam, Amit Nayyar, Prakash B Palde, Vikramdeep Monga, Rahul Jain, Sukhraj Kaur, Prati Pal Singh
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 12 Issue 15 Pg. 4179-88 (Aug 01 2004) ISSN: 0968-0896 [Print] England
PMID15246094 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Bacterial Agents
  • Carboxylic Acids
  • Esters
  • Quinolines
Topics
  • Anti-Bacterial Agents (chemical synthesis, chemistry, pharmacology)
  • Carboxylic Acids (chemical synthesis, chemistry, pharmacology)
  • Drug Design
  • Esters (chemical synthesis, chemistry, pharmacology)
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Mycobacterium tuberculosis (drug effects, genetics)
  • Quinolines (chemical synthesis, chemistry, pharmacology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: